Gumintad, Elita L.

HRN: 21-62-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
CEFTRIAXONE 1G (VIAL)
10/20/2022
10/26/2022
IV
2 Grams
Q 24 Hrs
Uti
Waiting Final Action 
10/20/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
10/20/2022
10/26/2022
IV
500 Mg
Q 8 Hrs
Amebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: